USPTO serial 99727485
LIWAYFA
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- TWAY, TATIANA R
- Law office
- TMEG LAW OFFICE 105
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with LIWAYFA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Thousand Oaks, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elsa D. Lemoine
Elsa D. Lemoine Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations;pharmaceutical preparations for the treatment of cancer;pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders;pharmaceutical preparations for the treatment of the respiratory system;pharmaceutical preparations for the treatment of the gastrointestinal diseases and disorders;pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic, and dermatitis;pharmaceutical preparations for the treatment of autoimmune diseases and disorders;pharmaceutical preparations for the treatment of asthma and other breathing disorders;pharmaceutical preparations for the treatment of obesity, diabetes, cardiovascular, central nervous system diseases and disorders, metabolic disorders, and stroke | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 19, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 19, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 19, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 6, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 6, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 12, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 12, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 26, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 26, 2026 | NWAP | NEW APPLICATION ENTERED | — |